Di Legge Silvia, Sallustio Fabrizio, De Marchis Emiliano, Rossi Costanza, Koch Giacomo, Diomedi Marina, Borzi Mauro, Romeo Francesco, Stanzione Paolo
Department of Clinical Neurological Sciences, Stroke Unit, University of Rome "Tor Vergata", Viale Oxford 81, 00133 Rome, Italy.
ISRN Neurol. 2011;2011:959483. doi: 10.5402/2011/959483. Epub 2011 Dec 15.
Purpose. We investigated stroke recurrence in patients with acute ischemic stroke of undetermined aetiology, with or without a patent foramen ovale (PFO). Methods. Consecutive stroke patients underwent to Transcranial Doppler and Transesophageal Echocardiography for PFO detection. Secondary stroke prevention was based on current guidelines. Results. PFO was detected in 57/129 (44%) patients. The rate of recurrent stroke did not significantly differ between patients with and without a PFO: 0.0% versus 1.4% (1 week), 1.7% versus 2.7% (1 month), and 3.5% versus 4.2% (3 months), respectively. The 2-year rates were 10.4% (5/48) in medically treated PFO and 8.3% (6/72) in PFO-negative patients (P = 0.65), with a relative risk of 1.25. No recurrent events occurred in 9 patients treated with percutaneous closure of PFO. Conclusion. PFO was not associated with increased rate of recurrent stroke. Age-related factors associated with stroke recurrence in cryptogenic stroke should be taken into account when patients older than 55 years are included in PFO studies.
目的。我们研究了病因不明的急性缺血性卒中患者(无论有无卵圆孔未闭[PFO])的卒中复发情况。方法。连续的卒中患者接受经颅多普勒和经食管超声心动图检查以检测PFO。二级卒中预防基于现行指南。结果。129例患者中有57例(44%)检测到PFO。有PFO和无PFO的患者之间卒中复发率无显著差异:分别为0.0%对1.4%(1周)、1.7%对2.7%(1个月)、3.5%对4.2%(3个月)。药物治疗PFO患者的2年复发率为10.4%(5/48),PFO阴性患者为8.3%(6/72)(P = 0.65),相对风险为1.25。9例接受经皮PFO封堵治疗的患者未发生复发事件。结论。PFO与卒中复发率增加无关。当PFO研究纳入55岁以上患者时,应考虑与隐源性卒中复发相关的年龄因素。